Cargando…

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic

BACKGROUND: Symptomatic invitees are advised not to participate in colorectal cancer (CRC) screening but to directly consult their general practitioner (GP), because fecal immunochemical test (FIT) sensitivity for cancer is not optimal. This recommendation may not always be followed in daily practic...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Klerk, Clasine M, van der Vlugt, Manon, Bossuyt, Patrick M, Dekker, Evelien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949972/ https://www.ncbi.nlm.nih.gov/pubmed/29774162 http://dx.doi.org/10.1177/2050640617733922

Ejemplares similares

Urban density differences in colorectal cancer screening participation and screening yield in The Netherlands
por: de Klerk, Clasine M., et al.
Publicado: (2022)

Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screening
por: Kortlever, Tim L., et al.
Publicado: (2021)

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
por: van der Vlugt, Manon, et al.
Publicado: (2017)

Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas
por: van der Vlugt, Manon, et al.
Publicado: (2022)

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012)

What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?
por: Flander, Louisa, et al.
Publicado: (2022)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands
por: Denters, Maaike J, et al.
Publicado: (2009)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing
por: van der Meulen, Miriam P., et al.
Publicado: (2022)

Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program
por: Vleugels, Jasper L. A., et al.
Publicado: (2017)

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
por: van de Schootbrugge-Vandermeer, Hilliene J., et al.
Publicado: (2023)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program
por: Rivero-Sánchez, Liseth, et al.
Publicado: (2018)

Clinical Features of Fecal Immunochemical Test-Negative Colorectal Lesions based on Colorectal Cancer Screening among Asymptomatic Participants in Their 50s
por: Suto, Shinya, et al.
Publicado: (2022)

Decision-making on colorectal cancer screening in Curaçao - interviews with the target population
por: Blake, Shacara N., et al.
Publicado: (2023)

Feasibility of Mass Screening for Colorectal Cancer Using Fecal Immunochemical Test in Iran
por: Kamangar, Farin, et al.
Publicado: (2017)

Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening
por: Ibuka, Takashi, et al.
Publicado: (2021)

The Accuracy of Fecal Immunochemical Test in Colorectal Cancer Screening: A Meta-Analysis
por: Phuangrach, Nittaya, et al.
Publicado: (2022)

Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
por: Osborne, Joanne M., et al.
Publicado: (2017)

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
por: Iovanescu, Dana, et al.
Publicado: (2016)

Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil
por: Teixeira, Cláudio R., et al.
Publicado: (2017)

Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test
por: Brenner, Hermann, et al.
Publicado: (2017)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
por: Liu, Feiyuan, et al.
Publicado: (2021)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
por: Ren, Yinan, et al.
Publicado: (2022)

Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
por: Flitcroft, Kathy L, et al.
Publicado: (2012)

Addition of an online, validated family history questionnaire to the Dutch FIT-based screening programme did not improve its diagnostic yield
por: Roos, Victorine H., et al.
Publicado: (2020)

The accuracy of polyp assessment during colonoscopy in FIT-screening is not acceptable on a routine basis
por: Stegeman, Inge, et al.
Publicado: (2014)

Accuracy of faecal immunochemical testing in patients with symptomatic colorectal cancer
por: Khan, A. A., et al.
Publicado: (2020)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
por: Malagón, Marta, et al.
Publicado: (2020)

Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms
por: Chiang, Tsung-Hsien, et al.
Publicado: (2015)

Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
por: Kim, Dae Ho, et al.
Publicado: (2018)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria
por: Knapp, Gregory C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ajelpijg51qnbsvcv12ulf4qr